Background No treatment has consistently shown efficacy in slowing disability progression
in patients with secondary progressive multiple sclerosis (SPMS). We assessed the effect of …

Background Comparative effectiveness (CE) research allows real-world treatment
comparisons using outcome measurements important to physicians/patients. This German …

Background and Objectives People with multiple sclerosis (MS) are a vulnerable group for
severe coronavirus disease 2019 (COVID-19), particularly those taking immunosuppressive …

Braune, S., Riedel, A., Schulte-Mönting, J. and Raczek, J. Influence of a Radiofrequency
Electromagnetic Field on Cardiovascular and Hormonal Parameters of the Autonomic Nervous …

Frequency and clinical importance of autonomic failure in idiopathic Parkinson’s disease (PD)
are discussed controversially. 141 patients with PD and 50 healthy age-matched control …

In idiopathic Parkinson's disease (IPD) approximately 60 % of the nigrostriatal neurons of
the substantia nigra (SN) are degenerated before neurologists can establish the diagnosis …

Scintigraphy with radiolabeled metaiodobenzylguanidine (MIBG) enables the visualization
and quantification of functionally intact adrenergic neurons and cells. In Parkinson disease, …

Bone pain after transplantation is a frequent complication that can be caused by several
diseases. Treatment strategies depend on the correct diagnosis of the pain. Nine patients with …

Background and Objectives Certain demographic and clinical characteristics, including the
use of some disease-modifying therapies (DMTs), are associated with severe acute …

Background: We need high-quality data to assess the determinants for COVID-19 severity in
people with MS (PwMS). Several studies have recently emerged but there is great benefit in …